LSK Global PS

Seoul, South Korea Full Service Founded 2006 201-500 employees

South Korean CRO providing Phase I-IV clinical development, bioanalytical services, and regulatory consulting with particular expertise in simultaneous MFDS-FDA-EMA regulatory submissions.

Services

CLINICAL

Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Clinical Data Management Biostatistics

ANALYTICAL

Bioanalytical Testing

REGULATORY

IND Filing Support Regulatory Strategy

Therapeutic Areas

Oncology CNS Cardiovascular Immunology Metabolic Disease

Contact

Locations

Seoul, South Korea

Certifications

GCP Compliant GLP ISO 9001

Regulatory Experience

FDAEMAPMDA